Gojo, Javelle B.

HRN: 28-18-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/11/2025
12/07/2025
IV
40mg As LD Then 20mg
Q8
Tetanus
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines